» Articles » PMID: 32919937

MiRNAs in Tuberculosis: Their Decisive Role in the Fate of TB

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 2020 Sep 13
PMID 32919937
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberculosis (TB) is one of the most lethal global infectious diseases. Despite the availability of much higher levels of technology in health and medicine, tuberculosis still remains a serious global health problem. Mycobacterium tuberculosis has the capacity for prolonged survival inside macrophages by exploiting host metabolic and energy pathways and perturbing autophagy and apoptosis of infected cells. The mechanism(s) underlying this process are not completely understood but evidence suggests that mycobacteria subvert the host miRNA network to enable mycobacterial survival. We present here a comprehensive review on the role of miRNAs in TB immune escape mechanisms and the potential for miRNA-based TB therapeutics. Further validation studies are required to (i) elucidate the precise effect of TB on host miRNAs, (ii) determine the inhibition of mycobacterial burden using miRNA-based therapies and (iii) identify novel miRNA biomarkers that may prove useful in TB diagnosis and treatment monitoring.

Citing Articles

Mmu-let-7a-5p inhibits macrophage apoptosis by targeting CASP3 to increase bacterial load and facilities mycobacterium survival.

Zhan X, Yuan W, Ma R, Zhou Y, Xu G, Ge Z PLoS One. 2024; 19(9):e0308095.

PMID: 39226319 PMC: 11371246. DOI: 10.1371/journal.pone.0308095.


Lipopolysaccharide-induced bacterial infection model: microRNA-370-3p participates in the anti-infection response by targeting the macrophage TLR4-NLRP3 caspase-1 cellular pyroptosis pathway.

Liu W, Chen H, Xia F, Lu L, Reyimu A, Pawuziye P Int J Immunopathol Pharmacol. 2024; 38:3946320241272550.

PMID: 39101927 PMC: 11301722. DOI: 10.1177/03946320241272550.


A systematic review and meta-analysis of circulating serum and plasma microRNAs in TB diagnosis.

Gunasekaran H, Sampath P, Thiruvengadam K, Malaisamy M, Ramasamy R, Ranganathan U BMC Infect Dis. 2024; 24(1):402.

PMID: 38622570 PMC: 11017603. DOI: 10.1186/s12879-024-09232-0.


Editorial: Exosomes and exosomal miRNAs as biomarkers in infection with Mycobacterium tuberculosis.

Alipoor S Front Cell Infect Microbiol. 2023; 13:1239739.

PMID: 37565065 PMC: 10411351. DOI: 10.3389/fcimb.2023.1239739.


Advances in computational frameworks in the fight against TB: The way forward.

Naidu A, Nayak S, Lulu S S, Sundararajan V Front Pharmacol. 2023; 14:1152915.

PMID: 37077815 PMC: 10106641. DOI: 10.3389/fphar.2023.1152915.